The results of this study suggest that caution should be taken in the use of blood pressure-lowering treatment in patients with coronary artery disease.
An editorial discusses the findings of this study, highlighting that the results warn against an extensive extrapolation of the results of the SPRINT trial which advocated that “the lower the achieved blood pressure, the better”, should be pursued in all individuals at high cardiovascular risk.